CONMED Corporation CNMD
47.08 USD +0.49 (+1.05%)
Nov 3, 2026, 3:53 PM EST
46.25 Day range 47.79
31.44 52-week range 53.66
- YTD
- +15.96%
- 1 year
- +4.95%
Analyst view
Consensus: hold
Hold
Price target (mean) 46.83 -0.5% downside
Now 47.08
- Target (low)
- 43.00
- Target (mean)
- 46.83
- Target (high)
- 50.00
Ratings (0m) 7 0 buy · 6 hold · 1 sell
- Strong buy0
- Buy0
- Hold6
- Sell0
- Strong sell1
Recommendation trend
- This month 7
- 1 month ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.26 | 1.26 – 1.27 | 1.43 | -11.6% | 366.55M | -1.8% | 7 |
| Next quarter | 0.98 | 0.90 – 1.10 | 0.89 | +10.1% | 329.30M | +3.9% | 5 |
| Current year | 4.57 | 4.56 – 4.58 | 4.59 | -0.4% | 1.36B | -0.9% | 7 |
| Next year | 4.75 | 4.63 – 4.91 | 4.57 | +3.9% | 1.43B | +4.7% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 29, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 30, 2026 | Piper Sandler | Reiterated | Neutral | Neutral |
| Jul 30, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 9, 2026 | BMO Capital | Initiated | — | Market Perform |
| Jun 29, 2026 | B of A Securities | Downgrade | Neutral | Underperform |
| May 18, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| May 1, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Apr 30, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Mar 17, 2026 | Piper Sandler | Downgrade | Overweight | Neutral |
| Jan 29, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jan 29, 2026 | Needham | Reiterated | Hold | Hold |
| Dec 8, 2025 | B of A Securities | Maintained | Neutral | Neutral |
| Nov 6, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Nov 6, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Nov 6, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 31, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Jun 12, 2025 | Needham | Downgrade | Buy | Hold |
| May 1, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| May 1, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| May 1, 2025 | Needham | Maintained | Buy | Buy |
| Apr 28, 2025 | Stifel | Downgrade | Buy | Hold |
| Feb 6, 2025 | Stifel | Maintained | Buy | Buy |
| Feb 6, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Feb 6, 2025 | Needham | Maintained | Buy | Buy |
| Feb 6, 2025 | JP Morgan | Downgrade | Overweight | Neutral |
| Oct 31, 2024 | Needham | Reiterated | Buy | Buy |
| Oct 4, 2024 | Needham | Reiterated | Buy | Buy |
| Aug 1, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 1, 2024 | Stifel | Maintained | Buy | Buy |